Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Lowered to $172.00 at Royal Bank of Canada
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by equities research analysts at Royal Bank of Canada from $182.00 to $172.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the specialty pharmaceutical company’s stock. Royal Bank of Canada’s price objective would indicate […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by equities research analysts at Royal Bank of Canada from $182.00 to $172.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the specialty pharmaceutical company’s stock. Royal Bank of Canada’s price objective would indicate […]
